Skip to content
The Nexus
DossierENTITY

Lars Engebretsen

Coverage of Lars Engebretsen in the Nexus archive.

Earliest in view: Jun 20 · 13:00 UTCMost recent: Jun 20 · 13:00 UTC
Co-mentioned in this coverage
Serena Williamsperson1Victoria Mbokoperson1Roorganization1World Anti-Doping Agencyorganization1GLP-1stopic1tirzepatidetopic1Thomas Hudzikperson1
Recent coverage
  • HEALTHJun 20 · 13:00 UTCTHE ATLANTIC
    Are GLP-1s Performance-Enhancing Drugs?

    Serena Williams, a paid spokesperson for telehealth company Ro, used GLP-1 weight-loss drugs to lose 34 pounds and claims the medication improved her training and tennis performance. The article explores whether GLP-1s should be classified as performance-enhancing drugs, noting the World Anti-Doping Agency is monitoring their use, though current rules allow athletes to take them.

Lars Engebretsen · Dossier · The Nexus